Why IMAX (IMAX) Is Back In The Spotlight
IMAX (NYSE:IMAX) is back in focus after recent analyst commentary highlighted its positive Earnings ESP and history of topping profit estimates. This combination has sharpened attention on the next results release.
Recent optimism around IMAX has focused on a stock that has already been in motion, with a 1-day share price return of 1.24% and a 7-day share price return of 2.71%. These moves have helped extend a 90-day share price return of 20.77% and a year-to-date share price return of 47.39%, while long-term investors have seen a 65.60% 1-year total shareholder return and very large multi year total shareholder gains that signal momentum has been building rather than fading.
Scan beyond IMAX and look for other potential momentum stories using the hand picked 21 high quality undiscovered gems that are already starting to attract attention.
After a 65.60% 1 year total return and strong multi year gains, IMAX is no longer a quiet backstory. At this price, does the risk reward still lean toward buyers once valuation enters the frame?
Most Popular Narrative: 10% Undervalued
IMAX closed at $53.09 against a most-followed fair value estimate of $59.17, which frames a market that is pricing in a lot of optimism but not all of the narrative assumptions.
The main thing that has to go right is that IMAX continues to convert its underpenetrated screen opportunity, strong box office titles such as The Odyssey, and growing local language and alternative content into sustained high incremental margins and recurring free cash flow.
High operating leverage in an asset light model, with management indicating that above roughly US$250 million quarterly box office about 85% of incremental revenue flows to the bottom line and guiding to mid 40s EBITDA margins with at least 50% free cash flow conversion, means further box office growth could have an outsized effect on earnings and cash generation.
See why 9 investors see IMAX as 10% undervalued.
Result: Fair Value of $59.17 (UNDERVALUED)
Still, the IMAX story can break if big screen attendance continues to give way to at-home entertainment or if a thinner blockbuster slate drags on the box office.
Find out about the key risks to this IMAX narrative.
Another View: IMAX On Earnings Multiples
IMAX screens as expensive on simple earnings ratios. The shares trade on a P/E of 71.1x compared with a fair ratio of 20.3x, the US Entertainment industry at 22x, and peer average of 47.4x. That gap points to meaningful valuation risk if expectations cool.
It leaves a basic question. Are you comfortable paying a premium P/E that far above the fair ratio and sector benchmarks, or does that spread feel like too much enthusiasm priced in already, especially after such strong recent returns, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed feelings about IMAX after all that do not need to stay that way. Act while the facts are fresh and weigh the 3 key rewards and 2 important warning signs.
Looking for more investment ideas beyond IMAX?
If IMAX has sharpened your focus, do not stop here. The next winning idea could already be on your radar, but only if you go looking.
- Target reliable cash generators by scanning a 33 high quality undervalued stocks that combines solid fundamentals with prices that have not fully reflected their financial strength.
- Protect your downside by filtering for a 31 resilient stocks with low risk scores that highlights businesses with stronger balance sheets and fewer red flags than the broader market.
- Spot future outperformance early by searching a 10 elite penny stocks with strong financials designed to surface smaller companies where improving quality has started to catch investors' attention.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com